These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 9385903)
21. Voltage-dependent calcium channel promoter restores baroreflex sensitivity in conscious dogs with heart failure. Uechi M; Asai K; Sato N; Vatner SF Circulation; 1998 Sep; 98(13):1342-7. PubMed ID: 9751685 [TBL] [Abstract][Full Text] [Related]
22. Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performance. Crawford MH; Richards KL; Sodums MT; Kennedy GT Am J Cardiol; 1984 Apr; 53(8):1051-3. PubMed ID: 6230926 [TBL] [Abstract][Full Text] [Related]
23. Effect of BAY y 5959 on myocardial function and metabolism in normal and failing hearts. Todaka K; Wang J; Yi GH; Gu A; Zhu SM; Zhang H; Burkhoff D Am J Physiol; 1998 May; 274(5):H1560-8. PubMed ID: 9612364 [TBL] [Abstract][Full Text] [Related]
24. Comparison of haemodynamic responses to cilnidipine and nicardipine in an experimental model of acute congestive heart failure. Noguchi K; Matsuzaki T; Koyama T; Itomine T; Sakanashi M Clin Exp Pharmacol Physiol; 1998; 25(7-8):541-7. PubMed ID: 9673425 [TBL] [Abstract][Full Text] [Related]
25. Acute effects of a single low oral dose of pimobendan on left ventricular systolic and diastolic function in patients with congestive heart failure. Ishiki R; Ishihara T; Izawa H; Nagata K; Hirai M; Yokota M J Cardiovasc Pharmacol; 2000 Jun; 35(6):897-905. PubMed ID: 10836724 [TBL] [Abstract][Full Text] [Related]
26. Combined inotropic and bradycardic effects of a sodium channel enhancer in conscious dogs with heart failure: a mechanism for improved myocardial efficiency compared with dobutamine. Shen W; Gill RM; Jones BD; Zhang JP; Corbly AK; Steinberg MI J Pharmacol Exp Ther; 2002 Nov; 303(2):673-80. PubMed ID: 12388650 [TBL] [Abstract][Full Text] [Related]
27. Cardiac and systemic sympathetic activity in response to clonidine in human heart failure. Azevedo ER; Newton GE; Parker JD J Am Coll Cardiol; 1999 Jan; 33(1):186-91. PubMed ID: 9935028 [TBL] [Abstract][Full Text] [Related]
28. Hemodynamic comparison of dopexamine and nitroprusside at high and low doses in patients with coronary artery disease and impaired left ventricular function. Ikram H; Foy SG; Low CJ; Redfern SA; Shirlaw TM; Bennett SI; Crozier IG J Cardiovasc Pharmacol; 1995 Nov; 26(5):777-83. PubMed ID: 8637193 [TBL] [Abstract][Full Text] [Related]
29. [Effect of Chinese-made vesnarinone on experimental heart failure of dog]. Du J; Yang Z Hua Xi Yi Ke Da Xue Xue Bao; 1992 Jun; 23(2):178-80. PubMed ID: 1452153 [TBL] [Abstract][Full Text] [Related]
30. Short-term effects of naloxone on hemodynamics and baroreflex function in conscious dogs with pacing-induced congestive heart failure. Himura Y; Liang CS; Imai N; Delehanty JM; Woolf PD; Hood WB J Am Coll Cardiol; 1994 Jan; 23(1):194-200. PubMed ID: 8277081 [TBL] [Abstract][Full Text] [Related]
32. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs. Pagel PS; Harkin CP; Hettrick DA; Warltier DC Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849 [TBL] [Abstract][Full Text] [Related]
33. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships. Givertz MM; Andreou C; Conrad CH; Colucci WS Circulation; 2007 Mar; 115(10):1218-24. PubMed ID: 17339544 [TBL] [Abstract][Full Text] [Related]
34. Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure. Wada K; Fujimori A; Matsukawa U; Arai Y; Sudoh K; Yatsu T; Sasamata M; Miyata K Eur J Pharmacol; 2005 Jan; 507(1-3):145-51. PubMed ID: 15659304 [TBL] [Abstract][Full Text] [Related]
35. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure. Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526 [TBL] [Abstract][Full Text] [Related]
36. Cardiovascular effects of AR-L115 BS in conscious dogs with and without chronic congestive heart failure. Pouleur H; Rousseau MF; van Mechelen H; Roncoroni L; Ries A; Charlier AA J Cardiovasc Pharmacol; 1982; 4(3):409-18. PubMed ID: 6177937 [TBL] [Abstract][Full Text] [Related]
37. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial. Follath F Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368 [TBL] [Abstract][Full Text] [Related]
38. Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure. Petein M; Levine TB; Cohn JN J Am Coll Cardiol; 1984 Aug; 4(2):364-71. PubMed ID: 6736478 [TBL] [Abstract][Full Text] [Related]
39. Pharmacology of SCH00013: a novel Ca2+ sensitizer. Endoh M; Sugawara H; Mineshima M Cardiovasc Drug Rev; 2001; 19(4):345-66. PubMed ID: 11830752 [TBL] [Abstract][Full Text] [Related]
40. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Slawsky MT; Colucci WS; Gottlieb SS; Greenberg BH; Haeusslein E; Hare J; Hutchins S; Leier CV; LeJemtel TH; Loh E; Nicklas J; Ogilby D; Singh BN; Smith W Circulation; 2000 Oct; 102(18):2222-7. PubMed ID: 11056096 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]